Mkts

Catalyst Pharmaceuticals, Inc.

NASDAQ: CPRX
$0.00—
As of Dec 31, 7:00 PM ET

Key statistics

52-week range
20.6632.56
Today
Open0.00
Previous close0.00
Volume—
Valuation
Market cap3.85B
P/E ratio17.42×
EPS (TTM)1.74
Income & risk
Dividend / yield—
Beta-0.05
Avg volume2.18M
Discussion

CPRX News

Stories mentioning CPRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue149,390152,613148,392146,563141,421141,820128,695122,710
Cost of Goods Sold14,47526,07422,65420,61417,91121,64319,27715,405
Gross Profit134,915126,539125,738125,949123,510120,177109,418107,305
Operating Expenses
Research & Development2,6611,8072,6574,3583,8873,7983,2842,985
Sales General & Admin49,31953,42147,47045,94946,91144,19245,88040,730
Total Operating Expenses51,98055,22850,12750,30750,79847,99049,16443,715
Operating Income (Loss)73,23261,84666,26766,29863,36762,84350,90954,246
Interest Income
Interest Expense
Other Expense10,99710,0554,7682,9957,91911,3386,2961,542
Pretax Income84,22971,90171,03569,29371,28674,18157,20555,788
Tax Provision20,49519,20318,25217,18514,54918,24513,32114,994
Net Income (Loss)63,73452,69852,78352,10856,73755,93643,88440,794
Earnings Per Share (Basic)0.520.430.430.430.470.470.370.35
Earnings Per Share (Diluted)0.500.410.420.410.450.450.350.33
Weighted Average Shares Outstanding (Basic)122,254122,291122,601122,163121,472118,458118,931118,180
Weighted Average Shares Outstanding (Diluted)126,903127,258127,090127,543126,958124,944125,407124,656

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CPRX

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol CPRX. It last traded at $0.0000 (Dec 31, 1969, 7:00 PM ET). That gives Catalyst Pharmaceuticals a market capitalisation of $3.9B and a price-to-earnings ratio of 17.4.

Over the past 52 weeks CPRX has traded between $20.66 and $32.56.

Revenue for the quarter ended Mar 31, 2026 was $149.4M; net income $63.7M. Revenue was up 5.6% from $141.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$149.4M$63.7M42.7%
Dec 31, 2025$152.6M$52.7M34.5%
Sep 30, 2025$148.4M$52.8M35.6%
Jun 30, 2025$146.6M$52.1M35.6%

From Catalyst Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…